In the last 12 months, insiders at Shattuck Labs, Inc. ($STTK) filed 134 transactions with the SEC: 17 open-market purchases totaling $11,237,366 and 5 sales totaling $585,236. Net insider sentiment: net buying.
Shattuck Labs, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ORBIMED ADVISORS LLC (Director) — 6 transactions totaling $5,471,826
- Ashiya Mona (Director) — 6 transactions totaling $5,471,826
- Redmile Group, LLC (Director) — 11 transactions totaling $2,900,648
- Neill Andrew R (Chief Financial Officer) — 12 transactions totaling $372,858
- Stout Stephen (See Remarks) — 19 transactions totaling $257,201
View all SEC Filings for Shattuck Labs, Inc. (STTK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 25, 2026 | Neill Andrew R | Chief Financial Officer | F | Common Stock | 2589 | $4.15 | 228,224.0000 | 72,184,818 | 1.12% | 0.00% |
| Jan. 25, 2026 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 3195 | $4.15 | 196,219.0000 | 72,184,818 | 1.60% | 0.00% |
| Jan. 25, 2026 | Stout Stephen | See Remarks | F | Common Stock | 593 | $4.15 | 81,529.0000 | 72,184,818 | 0.72% | 0.00% |
| Jan. 25, 2026 | DeYoung Casi | Chief Business Officer | F | Common Stock | 2286 | $4.15 | 73,480.0000 | 72,184,818 | 3.02% | 0.00% |
| Jan. 10, 2026 | Schreiber Taylor | Chief Executive Officer | A | Stock Option (Right to Buy) | 1548300 | $0.00 | 1,548,300.0000 | 72,184,818 | 9999.99% | 2.14% |
| Jan. 10, 2026 | Stout Stephen | See Remarks | F | Common Stock | 4153 | $4.75 | 82,122.0000 | 72,184,818 | 4.81% | 0.01% |
| Jan. 10, 2026 | Stout Stephen | See Remarks | A | Stock Option (Right to Buy) | 351400 | $0.00 | 351,400.0000 | 72,184,818 | 9999.99% | 0.49% |
| Jan. 10, 2026 | DeYoung Casi | Chief Business Officer | F | Common Stock | 5699 | $4.75 | 75,766.0000 | 72,184,818 | 7.00% | 0.01% |
| Jan. 10, 2026 | DeYoung Casi | Chief Business Officer | A | Common Stock | 381600 | $0.00 | 381,600.0000 | 72,184,818 | 9999.99% | 0.53% |
| Jan. 10, 2026 | Shukla Abhinav A. | Chief Technical Officer | A | Common Stock | 315500 | $0.00 | 315,500.0000 | 72,184,818 | 9999.99% | 0.44% |
| Jan. 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 6851 | $4.75 | 199,414.0000 | 72,184,818 | 3.32% | 0.01% |
| Jan. 10, 2026 | Pandite Arundathy N. | Chief Medical Officer | A | Common Stock | 487800 | $0.00 | 487,800.0000 | 72,184,818 | 9999.99% | 0.68% |
| Jan. 10, 2026 | Neill Andrew R | Chief Financial Officer | F | Common Stock | 6660 | $4.75 | 230,813.0000 | 72,184,818 | 2.80% | 0.01% |
| Jan. 10, 2026 | Neill Andrew R | Chief Financial Officer | A | Stock Option (Right to Buy) | 549800 | $0.00 | 549,800.0000 | 72,184,818 | 9999.99% | 0.76% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Common Warrants (right to buy) | 15366490 | $0.00 | 15,366,490.0000 | 50,758,290 | 9999.99% | 30.27% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Pre-Funded Warrants (right to buy) | 2022277 | $0.00 | 2,022,277.0000 | 50,758,290 | 9999.99% | 3.98% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Pre-Funded Warrants (right to buy) | 10111384 | $0.00 | 10,111,384.0000 | 50,758,290 | 9999.99% | 19.92% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Common Stock | 1051021 | $0.87 | 1,051,021.0000 | 50,758,290 | 9999.99% | 2.07% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Common Stock | 5255106 | $0.87 | 5,255,106.0000 | 50,758,290 | 9999.99% | 10.35% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Warrants (right to buy) | 3073298 | $0.00 | 3,073,298.0000 | 50,758,290 | 9999.99% | 6.05% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Warrants (right to buy) | 15366490 | $0.00 | 15,366,490.0000 | 50,758,290 | 9999.99% | 30.27% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Pre-Funded Warrants (right to buy) | 2022277 | $0.00 | 2,022,277.0000 | 50,758,290 | 9999.99% | 3.98% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Pre-Funded Warrants (right to buy) | 10111384 | $0.00 | 10,111,384.0000 | 50,758,290 | 9999.99% | 19.92% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 1051021 | $0.87 | 1,051,021.0000 | 50,758,290 | 9999.99% | 2.07% |
| Aug. 25, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 5255106 | $0.87 | 5,255,106.0000 | 50,758,290 | 9999.99% | 10.35% |
| Aug. 28, 2025 | Baker Daniel G. | Not found | A | Stock Option (Right to Buy) | 66300 | $0.00 | 66,300.0000 | 50,758,290 | 9999.99% | 0.13% |
| Aug. 28, 2025 | Ashiya Mona | Not found | A | Stock Option (Right to Buy) | 66300 | $0.00 | 66,300.0000 | 50,758,290 | 9999.99% | 0.13% |
| Aug. 25, 2025 | Ashiya Mona | Director | P | Common Warrants (right to buy) | 3073298 | $0.00 | 3,073,298.0000 | 50,758,290 | 9999.99% | 6.05% |
| Aug. 25, 2025 | Schreiber Taylor | Chief Executive Officer | A | Common Stock | 25610 | $0.87 | 2,707,362.0000 | 50,758,290 | 0.95% | 0.05% |
| Aug. 25, 2025 | SIEGALL CLAY B | Not found | A | Warrants (Right to Buy) | 128054 | $0.00 | 128,054.0000 | 50,758,290 | 9999.99% | 0.25% |
| Aug. 25, 2025 | SIEGALL CLAY B | Not found | A | Common Stock | 128054 | $0.87 | 128,054.0000 | 50,758,290 | 9999.99% | 0.25% |
| Aug. 25, 2025 | Neill Andrew R | Chief Financial Officer | A | Warrants (Right to Buy) | 64027 | $0.00 | 64,027.0000 | 50,758,290 | 9999.99% | 0.13% |
| Aug. 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | A | Common Stock | 5122 | $0.87 | 81,258.0000 | 50,758,290 | 6.73% | 0.01% |
| Aug. 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | A | Warrants (Right to Buy) | 5122 | $0.00 | 5,122.0000 | 50,758,290 | 9999.99% | 0.01% |
| Aug. 25, 2025 | Schreiber Taylor | Chief Executive Officer | A | Warrants (Right to Buy) | 25610 | $0.00 | 25,610.0000 | 50,758,290 | 9999.99% | 0.05% |
| Aug. 25, 2025 | Neill Andrew R | Chief Financial Officer | A | Common Stock | 64027 | $0.87 | 237,473.0000 | 50,758,290 | 36.91% | 0.13% |
| Aug. 25, 2025 | Stout Stephen | See Remarks | A | Warrants (Right to Buy) | 12805 | $0.00 | 12,805.0000 | 50,758,290 | 9999.99% | 0.03% |
| Aug. 25, 2025 | Stout Stephen | See Remarks | A | Common Stock | 12805 | $0.87 | 86,275.0000 | 50,758,290 | 17.43% | 0.03% |
| Aug. 25, 2025 | Redmile Group, LLC | Director | A | Pre-Funded Warrants to Purchase Common Stock | 4097730 | $0.00 | 7,198,553.0000 | 50,758,290 | 132.15% | 8.07% |
| Aug. 25, 2025 | Redmile Group, LLC | Director | A | Common Warrants to Purchase Common Stock | 4097730 | $0.00 | 4,097,730.0000 | 50,758,290 | 9999.99% | 8.07% |
| July 14, 2025 | Golumbeski George | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Brownstein Carrie | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Brous Tyler | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Boudreau Helen M | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Sasser Amy Kate | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | SIEGALL CLAY B | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Lee Michael Stewart | Director | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| July 14, 2025 | Gibson Neil W | Not found | A | Stock Option (Right to Buy) | 33150 | $0.00 | 33,150.0000 | 50,758,290 | 9999.99% | 0.07% |
| Jan. 25, 2025 | DeYoung Casi | Chief Business Officer | F | Common Stock | 2297 | $1.16 | 81,465.0000 | 50,758,290 | 2.74% | 0.00% |
| Jan. 25, 2025 | Shukla Abhinav A. | Chief Technical Officer | F | Common Stock | 2261 | $1.16 | 73,536.0000 | 50,758,290 | 2.98% | 0.00% |
| Jan. 28, 2025 | Shukla Abhinav A. | Chief Technical Officer | A | Common Stock | 165200 | $0.00 | 165,200.0000 | 50,758,290 | 9999.99% | 0.33% |
| Jan. 28, 2025 | DeYoung Casi | Chief Business Officer | A | Common Stock | 194300 | $0.00 | 194,300.0000 | 50,758,290 | 9999.99% | 0.38% |
| Jan. 25, 2025 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 3211 | $1.16 | 206,265.0000 | 50,758,290 | 1.53% | 0.01% |
| Jan. 28, 2025 | Pandite Arundathy N. | Chief Medical Officer | A | Common Stock | 206200 | $0.00 | 206,200.0000 | 50,758,290 | 9999.99% | 0.41% |
| Jan. 28, 2025 | Stout Stephen | See Remarks | A | Stock Option (Right to Buy) | 177000 | $0.00 | 177,000.0000 | 50,758,290 | 9999.99% | 0.35% |
| Jan. 28, 2025 | Neill Andrew R | Chief Financial Officer | A | Stock Option (Right to Buy) | 214000 | $0.00 | 214,000.0000 | 50,758,290 | 9999.99% | 0.42% |
| Jan. 28, 2025 | Schreiber Taylor | Chief Executive Officer | A | Stock Option (Right to Buy) | 684600 | $0.00 | 684,600.0000 | 50,758,290 | 9999.99% | 1.35% |
| Jan. 10, 2025 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 6884 | $1.19 | 209,476.0000 | 50,758,290 | 3.18% | 0.01% |
| Jan. 10, 2025 | DeYoung Casi | Chief Business Officer | F | Common Stock | 5727 | $1.19 | 83,762.0000 | 50,758,290 | 6.40% | 0.01% |
| Jan. 10, 2025 | Shukla Abhinav A. | Chief Technical Officer | F | Common Stock | 4830 | $1.19 | 74,597.0000 | 50,758,290 | 6.08% | 0.01% |
| Dec. 4, 2024 | Redmile Group, LLC | Director | J | Common Stock, par value $0.0001 per share | 1026888 | $1.25 | 4,512,836.0000 | 50,833,538 | 18.54% | 2.02% |
| Dec. 4, 2024 | Redmile Group, LLC | Director | J | Common Stock, par value $0.0001 per share | 1026888 | $1.25 | 5,539,724.0000 | 50,833,538 | 22.75% | 2.02% |
| Dec. 4, 2024 | Redmile Group, LLC | Director | S | Common Stock, par value $0.0001 per share | 133371 | $1.25 | 5,406,353.0000 | 50,833,538 | 2.41% | 0.26% |
| Dec. 4, 2024 | Redmile Group, LLC | Director | P | Common Stock, par value $0.0001 per share | 133371 | $1.25 | 5,539,724.0000 | 50,833,538 | 2.47% | 0.26% |
| Oct. 7, 2024 | Schreiber Taylor | Chief Executive Officer | P | Common Stock | 36500 | $1.21 | 2,681,752.0000 | 50,833,538 | 1.38% | 0.07% |
| June 28, 2024 | Brous Tyler | Not found | P | Common Stock | 3000 | $3.90 | 238,088.0000 | 42,600,190 | 1.28% | 0.01% |
| June 27, 2024 | Brous Tyler | Not found | P | Common Stock | 5416 | $3.89 | 235,088.0000 | 42,600,190 | 2.36% | 0.01% |
| June 26, 2024 | Schreiber Taylor | Chief Executive Officer | P | Common Stock | 14400 | $3.47 | 2,645,252.0000 | 42,600,190 | 0.55% | 0.03% |
| June 21, 2024 | Gibson Neil W | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Brous Tyler | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Brownstein Carrie | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Boudreau Helen M | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Golumbeski George | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Sasser Amy Kate | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | SIEGALL CLAY B | Not found | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 21, 2024 | Lee Michael Stewart | Director | A | Stock Option (Right to Buy) | 27700 | $0.00 | 27,700.0000 | 42,600,190 | 9999.99% | 0.07% |
| June 4, 2024 | Schreiber Taylor | Chief Executive Officer | M | Common Stock | 3050 | $3.57 | 2,630,852.0000 | 42,600,190 | 0.12% | 0.01% |
| June 4, 2024 | Schreiber Taylor | Chief Executive Officer | M | Stock Option (Right to Buy) | 3050 | $0.00 | 162,000.0000 | 42,600,190 | 1.85% | 0.01% |
| May 10, 2024 | Stout Stephen | See Remarks | F | Common Stock | 967 | $10.42 | 73,470.0000 | 42,600,190 | 1.30% | 0.00% |
| March 28, 2024 | Redmile Group, LLC | Director | J | Common Stock | 4425 | $0.00 | 5,615,489.0000 | 42,600,190 | 0.08% | 0.01% |
| March 6, 2024 | Stout Stephen | See Remarks | M | Common Stock | 6459 | $3.57 | 85,791.0000 | 42,600,190 | 8.14% | 0.02% |
| March 6, 2024 | Sasser Amy Kate | Not found | A | Stock Option (Right to Buy) | 33409 | $0.00 | 33,409.0000 | 42,600,190 | 9999.99% | 0.08% |
| March 6, 2024 | Stout Stephen | See Remarks | S | Common Stock | 6459 | $10.53 | 79,332.0000 | 42,600,190 | 7.53% | 0.02% |
| March 6, 2024 | Stout Stephen | See Remarks | S | Common Stock | 4895 | $10.53 | 74,437.0000 | 42,600,190 | 6.17% | 0.01% |
| March 6, 2024 | Stout Stephen | See Remarks | M | Stock Option (Right to Buy) | 6459 | $0.00 | 17,391.0000 | 42,600,190 | 27.08% | 0.02% |
| March 6, 2024 | Stout Stephen | See Remarks | M | Stock Option (Right to Buy) | 4650 | $0.00 | 9,300.0000 | 42,600,190 | 33.33% | 0.01% |
| March 6, 2024 | SIEGALL CLAY B | Not found | A | Stock Option (Right to Buy) | 33409 | $0.00 | 33,409.0000 | 42,600,190 | 9999.99% | 0.08% |
| March 6, 2024 | Stout Stephen | See Remarks | M | Common Stock | 4650 | $3.51 | 83,982.0000 | 42,600,190 | 5.86% | 0.01% |
| March 6, 2024 | Stout Stephen | See Remarks | S | Common Stock | 4650 | $10.53 | 79,332.0000 | 42,600,190 | 5.54% | 0.01% |
| Jan. 30, 2024 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 2920 | $9.99 | 216,360.0000 | 42,600,190 | 1.33% | 0.01% |
| Jan. 30, 2024 | Stout Stephen | See Remarks | F | Common Stock | 593 | $9.99 | 79,332.0000 | 42,600,190 | 0.74% | 0.00% |
| Jan. 30, 2024 | Shukla Abhinav A. | Chief Technical Officer | F | Common Stock | 2290 | $9.99 | 79,427.0000 | 42,600,190 | 2.80% | 0.01% |
| Jan. 30, 2024 | DeYoung Casi | Chief Business Officer | F | Common Stock | 2008 | $9.99 | 89,489.0000 | 42,600,190 | 2.19% | 0.00% |
| Jan. 12, 2024 | Schreiber Taylor | Chief Executive Officer | A | Stock Option (Right to Buy) | 330100 | $0.00 | 330,100.0000 | 42,600,190 | 9999.99% | 0.77% |
| Jan. 10, 2024 | Pandite Arundathy N. | Chief Medical Officer | A | Stock Option (Right to Buy) | 92950 | $0.00 | 92,950.0000 | 42,600,190 | 9999.99% | 0.22% |
| Jan. 10, 2024 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 2987 | $10.09 | 219,280.0000 | 42,600,190 | 1.34% | 0.01% |
| Jan. 10, 2024 | Pandite Arundathy N. | Chief Medical Officer | A | Common Stock | 46475 | $0.00 | 222,267.0000 | 42,600,190 | 26.44% | 0.11% |
| Jan. 10, 2024 | Neill Andrew R | Chief Financial Officer | A | Stock Option (Right to Buy) | 113000 | $0.00 | 113,000.0000 | 42,600,190 | 9999.99% | 0.27% |
| Jan. 10, 2024 | Neill Andrew R | Chief Financial Officer | S | Common Stock | 25000 | $10.00 | 173,446.0000 | 42,600,190 | 12.60% | 0.06% |
| Jan. 10, 2024 | Neill Andrew R | Chief Financial Officer | F | Common Stock | 2470 | $10.09 | 198,446.0000 | 42,600,190 | 1.23% | 0.01% |
| Jan. 10, 2024 | Neill Andrew R | Chief Financial Officer | A | Common Stock | 56500 | $0.00 | 200,916.0000 | 42,600,190 | 39.12% | 0.13% |
| Jan. 10, 2024 | DeYoung Casi | Chief Business Officer | A | Stock Option (Right to Buy) | 92400 | $0.00 | 92,400.0000 | 42,600,190 | 9999.99% | 0.22% |
| Jan. 10, 2024 | DeYoung Casi | Chief Business Officer | F | Common Stock | 1583 | $10.09 | 91,497.0000 | 42,600,190 | 1.70% | 0.00% |
| Jan. 10, 2024 | DeYoung Casi | Chief Business Officer | A | Common Stock | 46200 | $0.00 | 93,080.0000 | 42,600,190 | 98.55% | 0.11% |
| Jan. 10, 2024 | Stout Stephen | See Remarks | A | Stock Option (Right to Buy) | 98100 | $0.00 | 98,100.0000 | 42,600,190 | 9999.99% | 0.23% |
| Jan. 10, 2024 | Stout Stephen | See Remarks | A | Common Stock | 49050 | $0.00 | 79,925.0000 | 42,600,190 | 158.87% | 0.12% |
| Jan. 10, 2024 | Shukla Abhinav A. | Chief Technical Officer | A | Stock Option (Right to Buy) | 66850 | $0.00 | 66,850.0000 | 42,600,190 | 9999.99% | 0.16% |
| Jan. 10, 2024 | Shukla Abhinav A. | Chief Technical Officer | A | Common Stock | 33425 | $0.00 | 81,717.0000 | 42,600,190 | 69.21% | 0.08% |
| Dec. 21, 2023 | Redmile Group, LLC | Director | A | Pre-Funded Warrant to Purchase Common Stock | 3100823 | $0.00 | 3,100,823.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Redmile Group, LLC | Director | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Lee Michael Stewart | Director | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Boudreau Helen M | Not found | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Golumbeski George | Not found | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Gibson Neil W | Not found | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Brownstein Carrie | Not found | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 26, 2023 | Brous Tyler | Not found | A | Stock Option (Right to Buy) | 40258 | $0.00 | 40,258.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Stout Stephen | See Remarks | A | Common Stock | 15900 | $0.00 | 30,875.0000 | 0 | 106.18% | 0.00% |
| May 10, 2023 | Stout Stephen | See Remarks | A | Stock Option (Right to Buy) | 31800 | $0.00 | 31,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | Thomson Erin Ator | General Counsel | A | Stock Option (Right to Buy) | 48250 | $0.00 | 48,250.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | Shukla Abhinav A. | Chief Technical Officer | A | Stock Option (Right to Buy) | 52200 | $0.00 | 52,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | Pandite Arundathy N. | Chief Medical Officer | A | Common Stock | 37875 | $0.00 | 175,792.0000 | 0 | 27.46% | 0.00% |
| Jan. 25, 2023 | Pandite Arundathy N. | Chief Medical Officer | A | Stock Option (Right to Buy) | 69750 | $0.00 | 69,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | DeYoung Casi | Chief Business Officer | A | Common Stock | 27100 | $0.00 | 46,880.0000 | 0 | 137.01% | 0.00% |
| Jan. 25, 2023 | DeYoung Casi | Chief Business Officer | A | Stock Option (Right to Buy) | 54200 | $0.00 | 54,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | Schreiber Taylor | Chief Executive Officer | A | Stock Option (Right to Buy) | 165050 | $0.00 | 165,050.0000 | 0 | 50.00% | 0.00% |
| Jan. 25, 2023 | Neill Andrew R | Chief Financial Officer | A | Stock Option (Right to Buy) | 69850 | $0.00 | 69,850.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | Thomson Erin Ator | General Counsel | A | Common Stock | 24125 | $0.00 | 103,209.0000 | 0 | 30.51% | 0.00% |
| Jan. 25, 2023 | Shukla Abhinav A. | Chief Technical Officer | A | Common Stock | 26100 | $0.00 | 47,092.0000 | 0 | 124.33% | 0.00% |
| Jan. 25, 2023 | Neill Andrew R | Chief Financial Officer | A | Common Stock | 34925 | $0.00 | 144,416.0000 | 0 | 31.90% | 0.00% |
| Jan. 10, 2023 | Shukla Abhinav A. | Chief Technical Officer | F | Common Stock | 1933 | $3.03 | 20,992.0000 | 0 | 8.43% | 0.00% |
| Jan. 10, 2023 | Pandite Arundathy N. | Chief Medical Officer | F | Common Stock | 2987 | $3.03 | 137,917.0000 | 0 | 2.12% | 0.00% |
| Jan. 10, 2023 | DeYoung Casi | Chief Business Officer | F | Common Stock | 1583 | $3.03 | 19,780.0000 | 0 | 7.41% | 0.00% |